Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06903975 · ClinicalTrials.gov registry record · Phase 4
BoTox Into the Sternocleidomastoid Muscles (SCM)
A Phase 4 study of Neck Muscle Issue, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06903975: Recruiting Phase 4 study of Neck Muscle Issue, sponsored by Boston Medical Center.
NCT06903975 is a Phase 4 study of Neck Muscle Issue that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06903975, a Phase 4 study of Neck Muscle Issue, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.
Primary Outcome
A standard tape measure will be used and circumference recorded in centimeters
Conditions Studied
Interventions
- DRUG prabotulinumtoxinA-xvfs
Study Locations (1)
Massachusetts
- The Spiegel Center - Newton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
What NCT06903975 shows while recruiting
NCT06903975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Neck Muscle Issue appearing as the primary indexed condition, and to 1 intervention - of which prabotulinumtoxinA-xvfs is the first listed.
NCT06903975 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06903975 about?
NCT06903975 is a clinical study titled "BoTox Into the Sternocleidomastoid Muscles (SCM)". Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimmi...
What is the current status of trial NCT06903975?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2025-05-14. Estimated completion is 2026-03.
What conditions does trial NCT06903975 study?
This clinical trial studies the following conditions: Neck Muscle Issue.
What interventions are being tested in trial NCT06903975?
The interventions under investigation include: prabotulinumtoxinA-xvfs (DRUG).
Who is sponsoring clinical trial NCT06903975?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06903975 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06903975's enrollment target sits among peer trials
30 1552nd of 2000 higher than 368 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI